Hereditary ataxia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:183518
Who is this for?
Show terms as
1Active trials49Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary ataxia is a broad group of genetically determined neurological disorders characterized by progressive cerebellar dysfunction leading to impaired coordination and balance. This category encompasses a wide spectrum of conditions including the autosomal dominant spinocerebellar ataxias (SCAs), autosomal recessive ataxias such as Friedreich ataxia and ataxia-telangiectasia, X-linked ataxias, and mitochondrial ataxias. The primary body system affected is the central nervous system, particularly the cerebellum and its connections, though the spinal cord, peripheral nerves, brainstem, and other organ systems may also be involved depending on the specific subtype. Key clinical features shared across hereditary ataxias include progressive gait and limb ataxia (incoordination), dysarthria (slurred speech), oculomotor abnormalities (such as nystagmus and saccadic pursuit), and impaired balance. Depending on the specific genetic subtype, additional features may include peripheral neuropathy, pyramidal signs (spasticity, hyperreflexia), extrapyramidal features (dystonia, parkinsonism), cognitive impairment, seizures, cardiomyopathy, skeletal deformities, and visual or hearing loss. Age of onset varies widely, from early childhood to late adulthood, and the rate of progression differs substantially among subtypes. Currently, there is no curative treatment for most hereditary ataxias. Management is primarily supportive and symptomatic, including physical therapy, occupational therapy, speech therapy, and assistive devices to maintain mobility and independence. Specific pharmacological treatments exist for a few subtypes — for example, omaveloxolone (Skyclarys) has been approved for Friedreich ataxia. Genetic counseling is essential for affected individuals and their families. Research into gene therapy, antisense oligonucleotides, and other targeted molecular therapies is actively ongoing for several subtypes.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jun 2025Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta

Second Affiliated Hospital, School of Medicine, Zhejiang University

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Hereditary ataxia.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta
Actively Recruiting
PI: Zhi-Ying Wu, M.D&Ph.D (Second Affiliated Hospital of Zhejiang University ) · Sites: Hangzhou, Zhejiang; Shanghai

Specialists

Showing 25 of 49View all specialists →
LM
Lynne M. Bird, MD
GRAND JUNCTION, CO
Specialist
PI on 1 active trial1 Hereditary ataxia publication
LM
Laurent Servais, MD
Specialist
PI on 6 active trials1 Hereditary ataxia publication
CM
Carlos A. Bacino, MD
HOUSTON, TX
Specialist
PI on 2 active trials
MM
Michio Hirano, MD
NEW YORK, NY
Specialist
PI on 10 active trials
AM
Arthur L. Beaudet, MD
HOUSTON, TX
Specialist
PI on 1 active trial1 Hereditary ataxia publication
MM
Michael Goggins, MD
PHILADELPHIA, PA
Specialist
PI on 2 active trials
TM
Thomas Klopstock, MD
Specialist
PI on 4 active trials
SM
Steven A. Skinner, MD
Specialist
PI on 2 active trials
MM
Magdy Shenouda, M.D.
WALL, NJ
Specialist
PI on 3 active trials
WB
Wen-Hann Tan, BMBS
Specialist
PI on 6 active trials
AM
Alessandro Filla, MD
Specialist
PI on 3 active trials1 Hereditary ataxia publication
FM
Fumihiko Urano, MD
SAINT LOUIS, MO
Specialist
PI on 1 active trial
SD
Stefan Zielen, Prof. Dr.
Specialist
PI on 5 active trials
HP
Huma Arshad Cheema, Prof.
Lahore, NY
Specialist

Rare Disease Specialist

PI on 1 active trial
CP
Christophe Lenglet, Ph.D
Specialist
PI on 1 active trial
PP
Pierre-Gilles Henry, Ph.D.
Specialist
PI on 1 active trial
TM
Tetsuo Ashizawa, MD
GAINESVILLE, FL
Specialist
PI on 2 active trials
TM
Theresa Zesiewicz, MD
TAMPA, FL
Specialist
PI on 4 active trials
TT
Tatsuro Takei
Specialist
PI on 1 active trial5 Hereditary ataxia publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary ataxia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary ataxiaForum →

No community posts yet. Be the first to share your experience with Hereditary ataxia.

Start the conversation →

Latest news about Hereditary ataxia

No recent news articles for Hereditary ataxia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary ataxia

What is Hereditary ataxia?

Hereditary ataxia is a broad group of genetically determined neurological disorders characterized by progressive cerebellar dysfunction leading to impaired coordination and balance. This category encompasses a wide spectrum of conditions including the autosomal dominant spinocerebellar ataxias (SCAs), autosomal recessive ataxias such as Friedreich ataxia and ataxia-telangiectasia, X-linked ataxias, and mitochondrial ataxias. The primary body system affected is the central nervous system, particularly the cerebellum and its connections, though the spinal cord, peripheral nerves, brainstem, and

Are there clinical trials for Hereditary ataxia?

Yes — 1 recruiting clinical trial is currently listed for Hereditary ataxia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Hereditary ataxia?

25 specialists and care centers treating Hereditary ataxia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.